Should You Buy Optimer Pharmaceuticals, Inc. (OPTR)?
Should Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) investors track the following data? At the moment, there are plenty of metrics investors can use to...
Posts Tagged ‘Optimer Pharmaceuticals Inc (OPTR)’
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
Is Array Biopharma Inc (NASDAQ:ARRY) a good investment? At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most...
Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): How Could This Deal Shake Up an Entire Industry?
With two simultaneous moves that have set the pharmaceutical world on fire, Cubist Pharmaceuticals Inc (NASDAQ:CBST) has triumphantly announced its arrival...
Cubist Pharmaceuticals Inc (CBST), Forest Laboratories, Inc. (FRX): Marketed Drugs, Strong Pipeline, Long Term Growth Stock
In June this year, a drug candidate from Cubist Pharmaceuticals Inc (NASDAQ:CBST) received fast track status from the FDA. This product can potentially...
Cubist Pharmaceuticals Inc (CBST), Optimer Pharmaceuticals, Inc. (OPTR), Trius Therapeutics, Inc. (TSRX): Will This Biotech Company’s Big Bet Pay Off?
Cubist Pharmaceuticals Inc (NASDAQ:CBST) surged 10% on July 31, after the company acquired two antibiotic makers, Optimer Pharmaceuticals, Inc. (NASDAQ...
Is Merrimack Pharmaceuticals Inc (MACK) Going to Burn These Hedge Funds?
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has seen a decrease in hedge fund interest of late. According to most shareholders, hedge funds are seen as...
Hedge Funds Are Dumping Optimer Pharmaceuticals, Inc. (OPTR)
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) was in 11 hedge funds’ portfolio at the end of March. OPTR investors should be aware of a decrease in...
MannKind Corporation (MNKD), PDL BioPharma Inc. (PDLI) & Optimer Pharmaceuticals, Inc. (OPTR): 2 Biotechs to Avoid, 1 to Buy
Keeping a close eye on two particular classes of investors can tell you a lot about how stocks might move in the future. Institutional investors have...
AstraZeneca plc (ADR) (AZN): The Latest News
AstraZeneca plc (ADR) (NYSE:AZN)‘s in a tight spot. The big pharma’s sales and earnings have swung sharply lower recently, with patent expirations...
Should You Avoid Merrimack Pharmaceuticals Inc (MACK)?
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shareholders have witnessed a decrease in activity from the world’s largest hedge funds lately. To the...
GlaxoSmithKline plc (ADR) (GSK) & Three Humongous Healthcare Stocks This Week
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom. Here are three...
Johnson & Johnson (JNJ), Rigel Pharmaceuticals, Inc. (RIGL): This Week in Biotech
With the SPDR S&P Biotech Index up 22% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
This Week in Biotech: Dynavax Technologies Corporation (DVAX), Zogenix, Inc. (ZGNX)
With the SPDR S&P Biotech Index up 23% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
3 Humongous Health-Care Stocks Last Week: Orexigen Therapeutics, Inc. (OREX), Optimer Pharmaceuticals, Inc. (OPTR)
While the overall market seemed to be deciding this week whether to keep the rally going or take a break, several stocks in the world of health care left...
